These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26268451)

  • 41. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PLGA microdevices for retinoids sustained release produced by supercritical emulsion extraction: continuous versus batch operation layouts.
    Porta GD; Campardelli R; Falco N; Reverchon E
    J Pharm Sci; 2011 Oct; 100(10):4357-67. PubMed ID: 21638283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possibility for the development of cosmetics with PLGA nanospheres.
    Ito F; Takahashi T; Kanamura K; Kawakami H
    Drug Dev Ind Pharm; 2013 May; 39(5):752-61. PubMed ID: 22725249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles.
    Song B; Wu C; Chang J
    Acta Biomater; 2012 May; 8(5):1901-7. PubMed ID: 22326789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial efficacy of poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped cinnamon bark extract against Listeria monocytogenes and Salmonella typhimurium.
    Hill LE; Taylor TM; Gomes C
    J Food Sci; 2013 Apr; 78(4):N626-32. PubMed ID: 23464835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles.
    d'Angelo I; Parajó Y; Horváth A; Kéri G; La Rotonda MI; Alonso MJ
    J Microencapsul; 2010; 27(1):57-66. PubMed ID: 19545221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery.
    Tahara K; Sakai T; Yamamoto H; Takeuchi H; Kawashima Y
    Int J Pharm; 2008 Apr; 354(1-2):210-6. PubMed ID: 18178349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of formulation composition and process on the characteristics and in vitro release from PLGA-based sustained release injectables.
    Meeus J; Scurr DJ; Appeltans B; Amssoms K; Annaert P; Davies MC; Roberts CJ; Van den Mooter G
    Eur J Pharm Biopharm; 2015 Feb; 90():22-9. PubMed ID: 25448071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
    Mukerjee A; Vishwanatha JK
    Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Jan; 68(1):105-11. PubMed ID: 17870446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of biodegradable polymeric nanoparticles and their controlled drug delivery for tuberculosis.
    Malathi S; Balasubramanian S
    J Biomed Nanotechnol; 2011 Feb; 7(1):150-1. PubMed ID: 21485846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.
    Hines DJ; Kaplan DL
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):257-76. PubMed ID: 23614648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
    Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
    Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
    Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W
    Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis.
    Kumar G; Sharma S; Shafiq N; Pandhi P; Khuller GK; Malhotra S
    Drug Deliv; 2011 Jan; 18(1):65-73. PubMed ID: 20735202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
    Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
    Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.